Following administration of SNT and anti-TRPV1 miRNA injections, a downregulation in the expression levels of TRPV1, CaMKII, and CytC within the muscle tissue of MPS rats was observed; concurrently, mitochondrial damage exhibited improvement. The gene discussed is TRPV1; the disease is mucopolysaccharidosis.